Anastrozole Tablets Market to Grow at Robust CAGR in the COVID-19 Lockdown Scenario

 


Anastrozole Tablets Market: Introduction

Anastrozole is a drug to treat breast cancer. It is used solely for hormone receptor-positive breast cancer.It is also used to prevent breast cancer in women at high risk of menopause. Anastrozole belongs to the drug-inhibiting aromatase class. In the List of Essential Medicines of the World Health Organization, anastrozole is the best and most effective treatment for breast cancer in menopausal women. Companies such as Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., AstraZeneca Plc, Accord Healthcare, Mylan N.V. and Sun Pharma Ltd. are major players on the industry. Anastrozole tablets are also used by bodybuilders and athletes to minimise the development of oestrogen, which is a side effect of steroid use. 

The demand for anastrozole tablets market is estimated to be USD 278.1 million in 2020 and is projected to have a CAGR of 2.8 percent over the forecast years (2020-2027).

Anastrozole Tablets Market – Regional Analysis

North America accounted for the largest revenue share of anastrozole tablets market, followed by Europe in 2019 as a result of growing product launches. For example, in February 2012, AstraZeneca Plc launched the first ever direct-to-patient programme for those with a valid breast cancer prescription medication Arimidex (anastrozole) via a U.S. specialty pharmacy service provider for US$40 per month.

In addition, a growing launch of anastrozole tablets is also anticipated to further fuel growth of anastrozole tablets market in Asia Pacific in the near future. For example, Cooper Pharma, a pharmaceutical company specialising in generics/hormonal drugs, announced in September 2019 that one of its wholly-owned hormone product, ANAZBOL, was launched in New Delhi, India. The business is also expected to introduce ANAZBOL in 25 other countries with legal authorisation.

To Know More Information about Anastrozole Tablets Market Trend, click the link@ https://www.globenewswire.com/news-release/2020/05/05/2027670/0/en/Anastrozole-Tablets-Market-to-reach-US-347-7-Million-globally-at-CAGR-of-2-8-by-end-of-2027-CMI.html


Comments

Post a Comment

Popular posts from this blog

Global Biofeedback Measurement Instrument Market to Rise During the COVID-19 Crisis Period Owing to Increasing Consumer Awareness

Image
  Increasing cases of neurological disorders, including depression, anxiety, ADHD, and other dementias, are expected to fuel the market growth of the biofeedback instrument market during the forecast period. For example, according to the World Alzheimer's Study released by Alzheimer's Disease International (ADI), new cases of dementia across regions in 2015 were 4.9 million (49.0 percent) in Asia Pacific, 2.5 million (25.0 percent) in Europe, 1.7 million (18.0 percent) in the Americas and 0.8 million (8.0 per cent) in Africa. In addition, according to Parkinson's UK, about 137,000 people in the UK suffered from Parkinson's disease in 2015. Parkinson's disease is the second most common age-related neurodegenerative condition after Alzheimer's. For example, according to Parkinson's UK, the estimated number of people with Parkinson's disease in Northern Ireland in 2015 was 241, 157 of whom were male and 85 were female. The global biofeedback instrument mark...
Read more

Global Pro AV Market from Key End-use Sectors to Surge in the Near Future

 Overview of the market  Pro AV refers to the sophisticated integration of audio-video devices used for commercial purposes. Pro AV uses multiple aspects such as display components, cameras, audio components, monitors, controls, space planners, whiteboard companions, advanced features such as digital signage, and other supporting accessories. Both of these components help to enhance connectivity and coordination between offices in two separate locations. It is therefore used in a number of industries, including education, government, hospitality/retail, and others.  The global Pro AV market was estimated at US$ 246.5 billion in 2019 and is projected to have a CAGR of 11.2 per cent during the forecast years (2020-2027).  Market Trend The integration of telecommunications applications including such Skype is a big trend in the global Pro AV industry.  The main players on the market are the integration of Pro AV products with telecommunications applications such as...
Read more

High Incidence of Ragweed Allergy and Emergence of Covid-19 to Augment Growth of Ragweed Pollen Allergy Treatment Market

Image
  Ragweed pollen is one of the most common causes of seasonal allergies in various countries. Symptoms of ragweed pollen allergy include, runny nose or congestion, coughing or wheezing, sinus pressure, itchy, watery eyes, scratchy throat, and swollen, bluish-colored skin beneath the eyes. Market Dynamics High incidence of ragweed allergy is expected to propel growth of the global ragweedpollen allergy treatment market . For instance, according to Asthma and Allergy Foundation of America, ragweed allergy affects 10 to 20% of people in the U.S. Moreover, high prevalence of asthma is also expected to aid in growth of the market. For instance, according to The Global Asthma Report 2018, the prevalence of asthma symptoms was 23% and the prevalence of a medical diagnosis of asthma 12% in Brazil. Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global ragweed pollen allergy treatment market. For instance, globally, as of 5:10pm CET, 9 Fe...
Read more